Assessment of intraoperative pain during Mohs micrographic surgery (MMS): An opportunity for improved patient care - 17/08/16
Abstract |
Background |
Intraoperative pain during Mohs micrographic surgery (MMS) has not been characterized. However, many patients report postoperative pain on the day of MMS.
Objective |
We sought to determine if patients experience pain during their MMS visit.
Methods |
In phase I of this study, patients were asked to report intraoperative pain level using the verbal numerical rating scale (0-10) at discharge. In phase II, pain levels were assessed before each Mohs layer and at discharge, to determine whether pain was experienced throughout the day.
Results |
Pain was reported at some point during the MMS day for 32.8% of patients (n = 98). The mean pain number reported was 3.7 (range 1-8) out of 10. Pain was more commonly reported by patients who spent a longer time in the office, had 3 or more Mohs layers, and had a flap or graft repair. Patients most frequently reported pain with surgical sites of the periorbital area and nose.
Limitations |
Time between Mohs layers was not measured. There was nonstandardized use of intraoperative local anesthesia volume and oral pain medications.
Conclusion |
Some patients experience pain during MMS. However, the majority of patients report a low level of pain. Additional preventative measures could be considered in patients at higher risk.
Le texte complet de cet article est disponible en PDF.Key words : intraoperative pain, Mohs micrographic surgery, verbal numerical rating scale-11
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Presented in the Tromovitch Award Abstract Session at the American College of Mohs Surgery Annual Meeting, San Antonio, TX, April 30, 2015. |
Vol 75 - N° 3
P. 590-594 - septembre 2016 Retour au numéro
Article précédent
- Utility of recorded guided imagery and relaxing music in reducing patient pain and anxiety, and surgeon anxiety, during cutaneous surgical procedures: A single-blinded randomized controlled trial
- Murad Alam, Wanjarus Roongpisuthipong, Natalie A. Kim, Amita Goyal, Jillian H. Swary, Renata T. Brindise, Sanjana Iyengar, Natalie Pace, Dennis P. West, Mahesh Polavarapu, Simon Yoo
- Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome
- Nicholas F. Lawrence, Marc R. Hammond, Dennie T. Frederick, Yuhua Su, Dora Dias-Santagata, April Deng, M. Angelica Selim, Meera Mahalingam, Keith T. Flaherty, Mai P. Hoang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?